Antimicrobial Activities of Flavonoid Glycosides From Graptophyllum Grandulosum and Their Mechanism of Antibacterial Action
Antimicrobial Activities of Flavonoid Glycosides From Graptophyllum Grandulosum and Their Mechanism of Antibacterial Action
Antimicrobial Activities of Flavonoid Glycosides From Graptophyllum Grandulosum and Their Mechanism of Antibacterial Action
Abstract
Background: The search for new antimicrobials should take into account drug resistance phenomenon. Medicinal
plants are known as sources of potent antimicrobial compounds including flavonoids. The objective of this
investigation was to evaluate the antimicrobial activities of flavonoid glycosides from Graptophyllum grandulosum,
as well as to determine their mechanism of antibacterial action using lysis, leakage and osmotic stress assays.
Methods: The plant extracts were prepared by maceration in organic solvents. Column chromatography of the n-
butanol extract followed by purification of different fractions led to the isolation of five flavonoid glycosides. The
antimicrobial activities of extracts/compounds were evaluated using the broth microdilution method. The
bacteriolytic activity was evaluated using the time-kill kinetic method. The effect of extracts on the red blood cells
and bacterial cell membrane was determined by spectrophotometric methods.
Results: Chrysoeriol-7-O-β-D-xyloside (1), luteolin-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyranoside (2), chrysoeriol-
7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyranoside (3), chrysoeriol-7-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-(4"-
hydrogeno sulfate) glucopyranoside (4) and isorhamnetin-3-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-glucopyranoside (5)
were isolated from G. grandulosum and showed different degrees of antimicrobial activities. Their antibacterial
activities against multi-drug-resistant Vibrio cholerae strains were in some cases equal to, or higher than those of
ciprofloxacin used as reference antibiotic. The antibacterial activities of flavonoid glycosides and chloramphenicol
increased under osmotic stress (5% NaCl) whereas that of vancomycin decreased under this condition. V. cholerae
suspension treated with flavonoid glycosides, showed a significant increase in the optical density at 260 nm,
suggesting that nucleic acids were lost through a damaged cytoplasmic membrane. A decrease in the optical
density of V. cholerae NB2 suspension treated with the isolated compounds was observed, indicating the lysis of
bacterial cells. The tested samples were non-toxic to normal cells highlighting their good selectivity index.
Conclusions: The results of the present study indicate that the purified flavonoids from G. glandulosum possess
antimicrobial activities. Their mode of antibacterial activity is due to cell lysis and disruption of the cytoplasmic
membrane upon membrane permeability.
Keywords: Graptophyllum glandulosum, Acanthaceae, Flavonoid glycosides, Antibacterial, Antifungal, Mode of action
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
afford the MeOH extract. Part of this extract (235 g) was (C-3′), 152.3 (C-4′), 116.7 (C-5′), 121.9 (C-6′), 56.6
suspended in water (300 mL) and successively parti- (C-7′) for aglycone; 100.6 (C-1′′), 78.6 (C-2′′), 77.9
tioned with EtOAc and n-BuOH to yield 37 and 13 g of (C-3′′), 70.9 (C-4′′), 66.9 (C-5′′), 110.0 (C-1′′′), 78.1
extracts, respectively. Column chromatography of the (C-2′′′), 80.7 (C-3′′′), 65.8 (C-4′′′), 75.4 (C-5′′′) for
n-BuOH extract followed by purification of different sugar moiety. 1H NMR data (CD3OD, 600 MHz) δH:
fractions led to the isolation of five compounds. 6.70 (1H, s, H-3), 6.45 (1H, d, J = 2.1 Hz, H-6), 6.77 (1H,
d, J = 2.1 Hz, H-8), 7.52 (1H, d, J = 2.1 Hz, H-2′), 6.95
Structural identification of the isolated compounds (1H, d, J = 8.4 Hz, H-5′), 7.56(1H, dd, J = 8.4 and 2.1 Hz,
The structures of isolated compounds were determined H-6′), 3.98 (3H, s, H-7′) for aglycone; 5.16 (1H, d, J =
after interpretation of their physical, spectrometric and 7.1 Hz, H-1′′), 3.68 (1H, dd, J = 9.0 and 7.1, H-2′′), 3.63
spectroscopic data summarized in this subsection. (1H, m, H-3′′), 3.62 (1H, m, H-4′′), 3.98 (1H, m, H-5′′
Chrysoeriol-7-O-β-D-xyloside (1): yellow amorphous a), 3.48 (1H, t, J = 9.6, H-5′′b), 5.46 (1H, d, J = 1.7 Hz,
powder; molecular formula C21H20O10; 13C NMR H-1′′′), 3.98 (1H, m, H-2′′′), 3.56 (2H, brs, H-4′′′),
(CD3OD, 150 MHz) δC: 165.3 (C-2), 104.3 (C-3), 184.1 4.05 (1H, d, J = 9.4, H-5′′′a), 3.84 (1H, d, J = 9.4, H-5′′′
(C-4), 161.7 (C-5), 99.6 (C-6), 163.1 (C-7), 95.8 (C-8), b) for sugar moiety.
158.5 (C-9), 107.0 (C-10), 123.1 (C-1′), 110.5 (C-2′), Chrysoeriol-7-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-(4′
148.2 (C-3′), 151.0 (C-4′), 116.7 (C-5′), 121.9 (C-6′), ′-hydrogenosulfate) glucopyranoside (4): yellow amorph-
55.2 (C-7′) for aglycone; 100.9 (C-1′′), 74.4 (C-2′′), 77.3 ous powder; molecular formula C28H31NaO18S. 13C NMR
(C-3′′), 70.7 (C-4′′), 66.9 (C-5′′) for sugar moiety. 1H data (CD3OD, 150 MHz) δC: 166.8 (C-2), 104.5 (C-3),
NMR data (CD3OD, 600 MHz) δH: 6.62 (1H, s, H-3), 184.1 (C-4), 163.1 (C-5), 101.1 (C-6), 164.0 (C-7), 96.2
6.38 (1H, d, J = 2.1 Hz, H-6), 6.71 (1H, d, J = 2.1 Hz, (C-8), 159.0 (C-9), 107.2 (C-10), 123.6 (C-1′), 110.8
H-8), 7.44 (1H, d, J = 2.1 Hz, H-2′), 6.84 (1H, d, J = (C-2′), 149.6 (C-3′), 152.3 (C-4′), 116.9 (C-5′), 122.0
8.4 Hz, H-5′), 7.47 (1H, dd, J = 8.4 and 2.1 Hz, H-6′), (C-6′), 56.7 (C-7′) for aglycone; 100.9 (C-1′′), 74.5 (C-2′
3.87 (3H, s, H-7′) for aglycone; 4.95 (1H, d, J = 7.1 Hz, ′), 76.8 (C-3′′), 77.5 (C-4′′), 75.3 (C-5′′), 67.1 (C-6′′),
H-1′′), 3.37 (1H, m, H-2′′), 3.36 (1H, m, H-3′′), 3.49 102.4 (C-1′′′), 71.9 (C-2′′′), 72.3 (C-3′′′), 74.2 (C-4′′′),
(1H, m, H-4′′), 3.38 (1H, m, H-5′′a), 3.87 (1H, m, H-5′′ 69.8 (C-5′′′), 17.9 (C-6′′′) for sugar moiety. 1H NMR
b) for sugar moiety. data (CD3OD, 600 MHz) δH: 6.73 (1H, s, H-3), 6.56 (1H,
Luteolin-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyra- d, J = 2.1 Hz, H-6), 6.84 (1H, d, J = 2.1 Hz, H-8), 7.55 (1H,
noside (2): yellow powder; molecular formula d, J = 2.1 Hz, H-2′), 6.98 (1H, d, J = 8.4 Hz, H-5′), 7.59
C25H26O14. m.p. = 203 °C. 13C NMR data (CD3OD, (1H, dd, J = 8.4 and 2.1 Hz, H-6′), 3.99 (3H, s, H-7′) for
150 MHz) δC: 165.3 (C-2), 103.5 (C-3), 182.5 (C-4), aglycone; 5.15 (1H, d, J = 7.8 Hz, H-1′′), 3.61 (1H, dd, J =
162.9 (C-5), 99.7 (C-6), 163.1 (C-7), 94.9 (C-8), 157.4 9.1 and 7.8 Hz, H-2′′), 3.84 (1H, t, J = 9.1 Hz, H-3′′), 4.32
(C-9), 105.5 (C-10), 121.7 (C-1′), 114.2 (C-2′), 146.4 (1H, dd, J = 9.9 and 9.1 Hz, H-4′′), 3.89 (1H, m, H-5′′),
(C-3′), 150.5 (C-4′), 116.6 (C-5′), 119.7 (C-6′) for agly- 4.10 (1H, m, H-6′′a), 3.68 (1H, m, H-6′′b), 4.75 (1H, d, J
cone; 99.0 (C-1′′), 76.0 (C-2′′), 77.0 (C-3′′), 70.0 (C-4′ = 1.3 Hz, H-1′′′), 3.95 (1H, dd, J = 3.4 and 1.3, H-2′′′),
′), 66.1 (C-5′′), 109.3 (C-1′′′), 76.5 (C-2′′′), 79.7 (C-3′′ 3.72 (1H, dd, J = 9.5 and 3.4 Hz, H-3′′′), 3.32 (1H, t, J =
′), 64.5 (C-4′′′), 74.4 (C-5′′′) for sugar moiety. 1H 9.5 Hz, H-4′′′), 3.62 (1H, m, H-5′′′), 1.21 (3H, d, J =
NMR data (CD3OD, 600 MHz) δH: 6.75 (1H, s, H-3), 6.2 Hz, H-6′′′) for sugar moiety.
6.40 (1H, d, J = 2.1 Hz, H-6), 6.75 (1H, d, J = 2.1 Hz, Isorhamnetin-3-O-α-L-rhamnopyranosyl-(1 →
H-8), 7.44 (1H, d, J = 2.1 Hz, H-2′), 6.90 (1H, d, J = 6)-β-D-glucopyranoside (5): yellow amorphous powder;
8.4 Hz, H-5′), 7.47 (1H, dd, J = 8.4 and 2.1 Hz, H-6′) for molecular formula C28H32O15. 13C NMR data (CD3OD,
aglycone; 5.18 (1H, d, J = 7.1 Hz, H-1′′), 3.52 (1H, dd, J 150 MHz) δC: 159.8 (C-2), 135.7 (C-3), 179.8 (C-4),
= 9.0 and 7.1 Hz, H-2′′), 3.43 (1H, m, H-3′′), 3.41 (1H, 162.4 (C-5), 104.3 (C-6), 160.1 (C-7), 100.2 (C-8), 157.5
m, H-4′′), 3.78 (1H, dd, J = 9.7 and 3.4 Hz, H-5′′a), 3.42 (C-9), 108.6 (C-10), 123.0 (C-1′), 114.5 (C-2′), 148.4
(1H, dd, J = 9.7 and 3.4 Hz, H-5′′b), 5.34 (1H, d, J = (C-3′), 151.1 (C-4′), 116.2 (C-5′), 124.4 (C-6′), 56.7
1.3 Hz, H-1′′′), 3.75 (1H, m, H-2′′′), 3.30 (2H, d, J = (C-7′) for aglycone; 104.0 (C-1′′), 75.9 (C-2′′), 78.1
3.4 Hz, H-4′′′), 3.88 (1H, d, J = 9.3 Hz, H-5′′′a), 3.65 (C-3′′), 71.8 (C-4′′), 77.4 (C-5′′), 68.7 (C-6′′), 102.6
(1H, d, J = 9.3 Hz, H-5′′′b) for sugar moiety. (C-1′′′), 72.1 (C-2′′′), 72.3 (C-3′′′), 73.8 (C-4′′′), 69.8
Chrysoeriol-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylo- (C-5′′′), 18.0 (C-6′′′) for sugar moiety. 1H NMR data
pyranoside (3): yellow powder; molecular formula (CD3OD, 600 MHz) δH: 6.71 (1H, d, J = 2.2 Hz, H-6),
C26H28O4; melting point = 181.8 °C. 13C NMR (CD3OD, 7.09 (1H, d, J = 2.2 Hz, H-8), 7.91 (1H, d, J = 2.2 Hz,
150 MHz) δC: 166.6 (C-2), 104.5 (C-3), 184.0 (C-4), H-2′), 6.95 (1H, d, J = 8.5 Hz, H-5′), 7.72 (1H, dd, J = 8.5
162.9 (C-5), 100.9 (C-6), 164.4 (C-7), 95.9 (C-8), 158.9 and 2.2 Hz, H-6′), 3.98 (3H, s, H-7′) for aglycone; 5.30
(C-9), 107.0 (C-10), 123.4 (C-1′), 110.4 (C-2′), 149.5 (1H, d, J = 7.6 Hz, H-1′′), 3.49 (1H, dd, J = 9.1 and
7.6 Hz, H-2′′), 3.45 (1H, t, J = 9.1 Hz, H-3′′), 3.23 (1H, suspension was removed at the end of the various incuba-
t, J = 9.1 Hz, H-4′′), 4.40 (1H, m, H-5′′), 3.84 (1H, dd, J tion times and mixed with 1.95 mL of Buffer. The optical
= 12.1 and 1.9 Hz, H-6′′a), 3.42 (1H, m, H-6′′b), 4.53 densities were read in the same way.
(1H, d, J = 1.3 Hz, H-1′′′), 3.58 (1H, dd, J = 3.4 and 1.3,
H-2′′′), 3.47 (1H, dd, J = 9.5 and 3.4 Hz, H-3′′′), 3.25 Bacteriolytic assay
(1H, t, J = 9.5 Hz, H-4′′′), 3.41 (1H, m, H-5′′′), 1.10 The bacteriolytic activities of the isolated compounds were
(3H, d, J = 6.2 Hz, H-6′′′) for sugar moiety. determined using the time-kill kinetic method as previously
described [20] with slight modifications. Full growth of V.
Antimicrobial assay cholerae NB2 in MHB was diluted 100 times and incubated
Microorganisms at 37 °C to produce an OD600 of 0.8 as starting inoculum.
The microorganisms used in this study were consisted of Sample solutions were added to the starting bacterial
five bacterial strains namely Staphylococcus aureus ATCC suspension to give a final concentration of 2 × MIC and
25923, Vibrio cholerae NB2, PC2, SG24 (1) and CO6 [16]. incubated at 37 °C with shaking, then 100 μL was removed
Also included were two fungi Candida albicans ATCC from each tube at 0, 15, 30, 60, and 120 min and the optical
9002 and Cryptococcus neoformans IP95026. These bac- density measured at 600 nm. Vancomycin and tetracycline
teria and yeasts were obtained from our local stocks. were used as positive controls and the tubes without
isolated compounds served as negative controls.
Determination of minimum inhibitory concentration and
minimum microbicidal concentration Hemolytic assay
The minimum inhibitory concentration (MIC) values Whole blood (10 mL) from albino rats was collected by
were determined using the broth micro-dilution method cardiac puncture in EDTA tubes. The study was con-
as described earlier [17]. The MIC values were defined ducted according to the ethical guidelines of the Com-
as the lowest sample concentration that prevented the mittee for Control and Supervision of Experiments on
change in color indicating a complete inhibition of mi- Animals (Registration no. 173/CPCSEA, dated 28 Janu-
crobial growth. The lowest concentrations that yielded ary, 2000), Government of India, on the use of animals
no growth after the subculturing were taken as the mini- for scientific research. Erythrocytes were harvested by
mum microbicidal concentration (MMC) values [18]. centrifugation at room temperature for 10 min at 1000 x
Ciprofloxacin (Sigma-Aldrich, Steinheim, Germany) and g and were washed three times in PBS buffer [21]. The
amphotericin B (Merck, Darmstadt, Germany) were used cytotoxicity was evaluated as previously described [21].
as positive controls for bacteria and yeast respectively.
Statistical analysis
Study on mode of action Data were analyzed by one-way analysis of variance
MIC and MBC changes under osmotic stress condition followed by Waller-Duncan post hoc test. The experi-
Osmotic stress was induced by adding 5% NaCl (w/v) to mental results were expressed as the mean ± Standard
MHB. The MHB supplemented with 5% NaCl was then ster- Deviation (SD). Differences between groups were con-
ilized and used for the determination of a new MIC and sidered significant when p < 0.05. All analyses were per-
MBC values of the samples as previously described [17]. The formed using the Statistical Package for Social Sciences
incubation time was increased from 24 to 48 h at 37 °C. (SPSS, version 12.0) software.
7' 7'
OCH3 OR
3' OH 3' OH
2' 2'
4'' 4' 4'
5'' O 5'' O
HO 8 HO 4'' 8
O O 5' O O
HO 9 HO 9 5'
2'' 1' 2'' 1'
3'' OH 1'' 7 2 6' 3'' O 1'' 7 2 6'
O
6 10 3 6 10 3
5 4 5''' 1''' 5 4
4''' OH
OH O OH O
3''' 2'''
1 OH OH 2R=H
3 R = CH3
6''' OH
5''' 4'''
7'
OH OCH3
O
3'''
3' OH
2'
1''' 4'
2''' OH 7'
OCH3 8
O 5'
O 9
3' 1'
6'' OH 7 2 6'
O 2' 3 1'' HO 3''
4'' 4' 2''
5'' O 6
O 8 10 OH
O O 5 4 O
S HO 9 5' O OH
Na O 2'' 1' 5''
3'' OH 1'' 7 2 6' OH O 4''
O 6''
6 10 3 O
5 4 HO 2'''
1'''
OH O 5
3''' O
4 HO
4''' 5'''
OH
Fig. 1 Chemical structures of flavonoids (1–5) isolated from n-BuOH extract of aerial parts of G. grandulosum Turill. 1:chrysoeriol-7-O-β-D-xyloside;
2:luteolin-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyranoside; 3: chrysoeriol-7-O-β-D-apiofuranosyl-(1 → 2)-β-D-xylopyranoside; 4: chrysoeriol-7-O-α-
L-rhamnopyranosyl-(1 → 6)-β-D-(4"-hydrogenosulfate) glucopyranoside; 5:Isorhamnetin-3-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-glucopyranoside
Table 1 Antimicrobial activities of extracts, isolated compounds and reference antimicrobial drugs
Extracts/Compounds Inhibition V. cholerae V. cholerae V. cholerae V. cholerae S. aureus C. albicans C. neoformans
parameters SG24 (1) CO6 NB2 PC2 ATCC 25923 ATCC 9002 IP95026
MeOH extract MIC 512 512 256 512 256 > 2048 > 2048
MMC 512 512 512 1024 512 / /
MMC/MIC 1 1 2 2 2 / /
n-BuOH extract MIC 256 256 128 128 128 2048 2048
MMC 256 256 128 256 128 > 2048 > 2048
MMC/MIC 1 1 1 2 1 / /
EtOAc extract MIC 64 128 64 64 64 1024 512
MMC 128 128 64 64 64 1024 1024
MMC/MIC 2 1 1 1 1 1 2
1 MIC 16 8 8 8 4 32 8
MMC 16 8 16 8 8 64 8
MMC/MIC 1 1 2 1 2 2 1
2 MIC 16 16 8 8 4 64 16
MMC 32 16 16 8 8 64 32
MMC/MIC 2 1 2 1 2 1 2
3 MIC 32 64 32 32 8 32 16
MMC 64 128 32 64 16 32 16
MMC/MIC 2 2 1 2 2 1 1
4 MIC 8 8 8 8 4 8 4
MMC 16 8 8 8 4 8 8
MMC/MIC 2 1 1 1 1 1 2
5 MIC 32 16 16 16 8 64 32
MMC 32 16 16 16 8 128 64
MMC/MIC 1 1 1 1 1 2 2
Refa MIC 32 4 16 16 0.5 0.5 0.25
MBC 32 4 16 16 0.5 0.5 0.25
MBC/MIC 1 1 1 1 1 1 1
/: not determined; MIC Minimum Inhibitory Concentration, MMC Minimum Microbicidal Concentration; the MIC and MMC were measured in μg/mL; a:
amphotericin B for yeasts and ciprofloxacin for bacteria
1 and 2. The MIC values of chloramphenicol determined occurred during the initial period (≤ 15 min), followed
under osmotic stress condition were smaller than those de- by a slight increase with prolonged incubation period.
termined under normal conditions. However, all the MIC At the same time, the OD260 of the control without
values of vancomycin determined under osmotic stress compound was not changed. These results suggest that
were higher than those determined under normal condi- flavonoid glycosides from G. glandulosum damage the
tions. Table 1 further shows that under osmotic stress, the cytoplasmic membrane and cause loss of intracellular
antibacterial activities of compounds 1, 2 and 4 against V. components. The highest values of OD260 were recorded
chorae SG24 (1), V. chorae CO6, V. chorae NB2 and V. with compound 4 for all the V. cholerae strains, whereas
chorae PC2 were higher than that of vancomycin. the least OD260 values were noticed with compound 2,
indicating that compound 4 released the highest
Effect of flavonoid glycosides on cell membrane amounts of nucleic acids followed in decreasing order by
The effect of flavonoid glycosides of G. glandulosum was compound 1, then 2.
evaluated in terms of leakage of UV 260 absorbing ma-
terial through the bacterial cell membrane (Fig. 2). After Bacteriolytic effect of compounds 1, 2 and 4
treatment with flavonoid glycosides at MIC values of The result on the leakage of 260 nm absorbing material
compounds 1, 2 and 4, the OD260 values of filtrates of was consistent with that of bacteriolysis (Fig. 3). This re-
all test strains increased and most of the leakage sult showed a decrease in the optical density of
Table 2 Antibacterial activities in terms of MIC (μg/mL) of compounds 1, 3 and 4 under osmotic stress condition against bacterial strains
Bacteria Compound 1 Compound 2 Compound 4 Chloramphenicol Vancomycin
0% NaCl 5% NaCl 0% NaCl 5% NaCl 0% NaCl 5% NaCl 0% NaCl 5% NaCl 0% NaCl 5% NaCl
V. chorae SG24 (1) 16 8 16 16 8 4 4 1 16 64
V. cholerae CO6 8 4 16 4 8 2 16 2 16 32
V. cholerae NB2 8 4 8 2 8 2 64 1 32 64
V. cholerae PC2 8 4 8 2 8 2 16 1 32 64
S. aureus 4 2 4 2 4 1 32 0.5 0,5 1
suspension treated with compounds 1, 2 and 4. After the test microbial species, the result can be considered
120 min, compounds 1, 2 and 4 induced a decline in cell as promising for the development of new antimicrobial
turbidity of 93.20, 94.36 and 95.16%, respectively in bac- drugs. The antimicrobial activities of purified flavonoids
teria suspension compared to time 0, indicating the lysis corroborated with those of early reports against bacteria
of bacterial cells. and fungi [5, 11, 26–28]. The antibacterial activity of the
samples against V. cholerae and S. flexneri are particu-
Haemolytic activity larly noteworthy since these strains were MDR clinical
The haemolytic activities of extracts and compounds 1–5 isolates which were resistant to commonly used drugs
against red blood cells (RBCs) were investigated using Tri- such as ampicillin, streptomycin, nalidixic acid, furazoli-
ton X-100 as a positive control. The positive control done and co-trimoxazole [16, 29, 30].
showed about 100% lysis, whereas the phosphate buffer Antimicrobial cutoff points have been defined in the lit-
saline (PBS) showed no lysis of RBCs. Interestingly, none erature to enable the understanding of the effectiveness of
of the tested samples showed haemolytic activities against pure compounds as follows: highly active: MIC below
RBCs at concentrations up to 256 and 2048 μg/mL for 1 μg/mL (or 2.5 μM), significantly active: 1 ≤ MIC ≤10 μg/
isolated compounds and extracts respectively (results not mL (or 2.5 ≤ MIC < 25 μM), moderately active: 10 < MIC
shown). This finding highlights the fact that the observed ≤100 μg/mL (or 25 < MIC ≤250 μM), weakly active: 100 <
biological efficacy was not due to haemolysis. MIC ≤1000 μg/mL (or 250 < MIC ≤2500 μM and not ac-
tive: MIC > 1000 μg/mL (or > 2500 μM) [25]. Based on
Discussion this, the antimicrobial activities of all the tested flavonoid
The antimicrobial activity of a plant extract is considered glycosides could be considered as significant or moderate
to be highly active if the MIC < 100 μg/mL; significantly against the specific microorganisms.
active when 100 ≤ MIC ≤512 μg/mL; moderately active The antimicrobial activities of the isolated compounds
when 512 < MIC ≤2048 μg/mL; weakly active if MIC > from G. glandulosum were in this order: compound 4 >
2048 μg/mL and not active when MIC > 10,000 μg/mL compound 1 > compound 2 > compound 5 > compound
[25]. Hence, the EtOAc extract of G. glandulosum was 3. Very little is known about the structure–function rela-
highly active (MIC < 100 μg/mL) against V. cholerae SG24 tionships of natural antimicrobials, but it seems that dif-
(1), V. cholerae NB2, V. cholerae PC2 and S. aureus; signifi- ferent substituent groups within the compounds had a
cantly active (100 ≤ MIC ≤512 μg/mL) against V. cholerae great influence on their biophysical and biological prop-
CO6 and C. neoformans; moderately active (512 < MIC erties [31]. Structural features such as the presence of an
≤2048 μg/mL) on C. albicans. The MeOH and n-BuOH aromatic ring, the sugar moiety or the numbers of hy-
extracts were significantly active against the test bacterial droxyl and methoxyl groups can significantly change
species; weakly and moderately active against the yeast membrane permeability and subsequent affinity to exter-
cells respectively. nal and internal binding sites in the bacteria, thus influ-
In this study, we also investigated if the mode of action encing the compound’s antimicrobial properties [32].
of flavonoid compounds is bactericidal or bacteriostatic. The antibacterial activities of flavonoid glycosides and
The results of the MMC values were fourfold lesser than chloramphenicol increased under osmotic stress (5%
their corresponding MIC values. This observation sug- NaCl) whereas that of vancomycin decreased under this
gests that the actions of extracts from G. glandulosum and condition. The results were supported by the observa-
their isolated flavonoid glycosides were bactericidal [11]. tion that certain bacterial strains (E. coli, S. aureus, P.
The antibacterial activities of flavonoid glycosides were aeruginosa) can survive under osmotic stress conditions
in some cases equal to, or higher than those of cipro- [33]. At low water activity, lipid composition of bacterial
floxacin used as reference antibiotic, suggesting that they cell membrane was changed [34]. This incident might
might be effective antibiotics against these pathogenic lead to occurrence of more antibacterial binding site on
bacteria. Taking into account the medical importance of cell membrane of bacteria and cause less resistance to
Fig. 2 Appearance of 260-nm-absorbing material in the filtrates of V. cholerae SG24 (1), PC2, NB2 and CO6 after treatment with compounds 1, 2
and 4. Bars represent the mean ± standard deviation of the triplicate OD at each incubation time. At the same incubation time, letters a-d
indicate significant differences between samples according to one way ANOVA and Waller Duncan test; p < 0.05
Fig. 3 Bacteriolytic effect of compounds 1, 2 and 4 against V. cholerae NB2. Results represent the mean ± standard deviation of the triplicate OD
at each incubation time
7. Mills S, Bone K. Principles and practice of phytotherapy –modern herbal Terminalia chebula against multi-drug resistant Shigella species. J Med
medicine. New York: Churchill Livingstone. 2000:31–4. Microbiol. 2015;64:901–9.
8. Evans WC. Trease and Evans Pharmacognosy. 15th ed. New York: W B 31. Mandalari G, Bennett RN, Bisignano G, Trombetta D, Saija A, Faulds CB, et al.
Saunders; 2002. p. 246–8. Antimicrobial activity of flavonoids extracted from bergamot (Citrus
9. Benavente-Garcia O, Castillo J, Marin FR, Ortuno A, Del Rio JA. Uses and bergamia Risso) peel a byproduct of the essential oil industry. J Appl
properties of citrus flavonoids. J Agric Food Chem. 1997;45:4505–15. Microbiol. 2007;103:2056–64.
10. Vuorela S, Kreander K, Karonen M, Nieminen R, Hämäläinen M, Galkin A, et 32. Fitzgerald DJ, Stratford M, Gasson MJ, Ueckert J, Bos A, Narbad A. Mode of
al. Preclinical evaluation of rapeseed raspberry and pine bark phenolics for antimicrobial action of vanillin against Escherichia coli, Lactobacillus
health related effects. J Agric Food Chem. 2005;53:5922–31. plantarum and Listeria innocua. J Appl Microbiol. 2004;97:104–13.
11. Djouossi MG, Tamokou JD, Ngnokam D, Kuiate JR, Tapondjou AL, Harakat D, 33. Besten HMW, Mols M, Moezelaar R, Zwietering MH, Abee T. Phenotypic and
et al. Antimicrobial and antioxidant flavonoids from the leaves of Oncoba transcriptomic analyses of mildly and severely salt-stressed Bacillus cereus
spinosa Forssk (Salicaceae). BMC Complement Altern Med. 2015;15:134. ATCC 14579 cells. Appl Environ Microbiol. 2009;75:111–9.
12. Barker RM. Graptophyllum nees. J Adel Bot Gard. 1986;9:156–66. 34. Beales N. Adaptation of microorganisms to cold temperatures weak acid
13. Ngoufack TC, Ngnokam D, Harakat D, Voutquenne-Nazabadioko L. Three reservatives low pH and osmotic stress: a review. Compr Rev Food Sci Food
new flavonoid glycosides from the aerial parts of Graptophyllum Saf. 2004;3:1–20.
grandulosum Turril (Acanthaceae). Phytochem Lett. 2017;19:172–5. 35. McMahon MAS, Xu J, Moore JE, Blair IS, McDowell DA. Environmental stress
14. Wahyuningtyas E. The Graptophylum pictum effect on acrylic resin complete and antibiotic resistance in food-related pathogens. Appl Environ Microbiol.
denture plaque growth. Dent J (Maj Kedokt Gigi). 2005;38:201–14. 2007;73:211–7.
15. Jiangseubchatveera N, Liawruangrath B, Liawruangrath S, Teerawutgulrag A, 36. Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, et al.
Santiarwarn D, Korth J, et al. The chemical constituents and the cytotoxicity The mode of antibacterial action of the essential oil of Melaleuca alternifolia
antioxidant and antibacterial activities of the essential oil of Graptophyllum (tea tree oil). J Appl Microbiol. 2000;88:170–5.
pictum (L) Griff. J Essent Oil Bear Pl. 2015;18:11–7. 37. Devi K, Kapila S. Antibacterial effect of some Indian liverworts. Int J Pharm
16. Bag PK, Bhowmik P, Hajra TK, Ramamurthy T, Sarkar P, Majumder M, et al. Sci Rev Res. 2013;20:219–21.
Putative virulence traits and pathogenicity of Vibrio cholerae non-O1 non- 38. Cushnie TTP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob
O139 isolated from surface waters in Kolkata India. Appl Environ Microbiol. Agents. 2005;26:343–56.
2008;74:5635–44. 39. Cushnie TTP, Lamb AJ. Recent advances in understanding the antibacterial
17. Fondjo ES, Dimo KSD, Tamokou JD, Tsemeugne J, Kouamo S, Ngouanet D, properties of flavonoids. Int J Antimicrob Agents. 2011;38:99–107.
et al. Synthesis characterization antimicrobial and antioxidant activities of
the homocyclotrimer of 4-Oxo-4h-thieno[34-C]chromene-3diazonium
sulfate. Open Med Chem J. 2016;10:21–32.
18. Joubouhi C, Tamokou JD, Ngnokam D, Voutquenne-Nazabadioko L, Kuiate
JR. Iridoids from Canthium subcordatum iso-butanol fraction with potent
biological activities. BMC Complement Altern Med. 2017;17:17.
19. Carson CF, Mee BJ, Riley TV. Mechanism of action of Melaleuca alternifolia
(tea tree) oil on Staphylococcus aureus determined by time kill, lysis, leakage
and salt tolerance assays and electron microscopy. Antimicrob Agents
Chemother. 2002;46:1914–20.
20. Ooi N, Miller K, Hobbs J, Rhys-Williams W, Love W, Chopra I. XF-73 a novel
antistaphylococcal membrane active agent with rapid bactericidal activity. J
Antimicrob Chemother. 2009;64:735–40.
21. Situ H, Bobek LA. In vitro assessment of antifungal therapeutic potential of
salivary histatin-5 two variants of histatin-5 and salivary mucin (MUC7)
domain 1. Antimicrob Agents Chemother. 2000;44:1485–93.
22. Markham KR, Ternai B, Stanley R, Geiger H, Mabry TJ. Carbon-13 NMR
studies of flavonoids III naturally occurring flavonoid glycosides and their
acylated derivatives. Tetrahedron. 1978;34:1389–97.
23. Koffi EN, Le Guernevéc C, Lozanoa PR, MeudeccAdjéd FA, Bekrob YA,
Lozanoa YF. Polyphenol extraction and characterization of Justicia secunda
Vahl leaves for traditional medicinal uses. Ind Crop Prod. 2013;49:682–9.
24. Mona-Antonia B, Hanns H. Flavonol glycosides from Eschscholtzia californica.
Phytochemistry. 1999;50:329–32.
25. Tamokou JD, Mbaveng TA, Kuete V. Antimicrobial activities of African
medicinal spices and vegetables. In: Medicinal spices and vegetables from
Africa: therapeutic potential against metabolic inflammatory infectious and
systemic diseases 1st edition Elsevier chapter 8 pp 207–237 2017.
26. Tatsimo NSJ, Tamokou JD, Havyarimana L, Dezső C, Forgo P, Hohmann J, et
al. Antimicrobial and antioxidant activity of kaempferol rhamnoside
derivatives from Bryophyllum pinnatum. BMC Res Notes. 2012;5:158.
27. Mabou FD, Tamokou JD, Ngnokam D, Voutquenne-Nazabadioko L, Kuiate
JR, Bag PK. Complex secondary metabolites from Ludwigia leptocarpa with
potent antibacterial and antioxidant activities. Drug Discover Therap. 2016;
10:141–9.
28. Tatsimo NSJ, Tamokou JD, Tsague TV, Lamshoft M, Sarkar P, Bag PK, et al.
Antibacterial-guided isolation of constituents from Senna alata leaves with a
particular reference against multi-drug-resistant Vibrio cholerae and Shigella
flexneri. Int J Biol Chem Sci. 2017;11:46–53.
29. Thakurta P, Bhowmik P, Mukherjee S, Hajra TK, Patra A, Bag PK. Antibacterial
antisecretory and antihemorrhagic activity of Azadirachta indica used to
treat cholera and diarrhea in India. J Ethnopharmacol. 2007;111:607–12.
30. Acharyya S, Sarkar P, Saha DR, Patra A, Ramamurthy T, Bag PK. Intracellular
and membrane damaging activities of methyl gallate isolated from
1. use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
2. use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
3. falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
4. use bots or other automated methods to access the content or redirect messages
5. override any security feature or exclusionary protocol; or
6. share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at